Research Progress on the Application and Mechanisms of Baihe Dihuang Decoction in Major Depressive Disorder
BHDH possesses a multi-target pharmacological basis for antidepressant activity. Existing clinical evidence supports its effectiveness and relative safety as an adjunctive therapy for MDD. To better define its clinical role and advance TCM modernization, future research should prioritize rigorous randomized controlled trials, elucidate its formula compatibility mechanisms, and identify its key bioactive components.
Authors
- Hejia Wan (ORCID: https://orcid.org/0009-0003-3900-1967)
- Y. Liu
- Yi Tian Liu
- Yanle Zhi
- Hao Feng
- Yilong wang
- Fengjiao Zhang
- Longlong Yang
- Zhiqiang Zhang
- Guimin Xue
Institutions
- Henan University of Traditional Chinese Medicine (CN)
- Henan University of Technology (CN)
- Henan Provincial People's Hospital (CN)
- First Affiliated Hospital of Henan University (CN)
- Henan Agricultural University (CN)
- Henan University of Economic and Law (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/dddt.s579207
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Postdoctoral Science Foundation
- Natural Science Foundation of Henan Province